Targeting Staufen 1 with antisense oligonucleotides for treating ALS and SCA2

Daniel R. Scoles(University of Utah), Stefan M. Pulst(University of Utah)
bioRxiv (Cold Spring Harbor Laboratory)
November 17, 2022
Cited by 6


Related Papers